Zealand Pharma A/S (ZLDPF)
48.24
-2.27
(-4.49%)
USD |
OTCM |
Aug 24, 16:00
Zealand Pharma Total Liabilities (Quarterly) : 269.50M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 269.50M |
| March 31, 2026 | 128.29M |
| December 31, 2025 | 256.49M |
| September 30, 2025 | 257.31M |
| June 30, 2025 | 247.22M |
| March 31, 2025 | 117.82M |
| December 31, 2024 | 337.25M |
| September 30, 2024 | 111.79M |
| June 30, 2024 | 109.15M |
| March 31, 2024 | 108.43M |
| December 31, 2023 | 237.99M |
| September 30, 2023 | 50.93M |
| June 30, 2023 | 47.22M |
| March 31, 2023 | 97.32M |
| December 31, 2022 | 250.89M |
| September 30, 2022 | 95.54M |
| June 30, 2022 | 105.66M |
| March 31, 2022 | 168.68M |
| December 31, 2021 | 174.28M |
| September 30, 2021 | 74.03M |
| June 30, 2021 | 85.71M |
| March 31, 2021 | 80.13M |
| December 31, 2020 | 87.55M |
| September 30, 2020 | 73.91M |
| June 30, 2020 | 71.11M |
| Date | Value |
|---|---|
| March 31, 2020 | 50.91M |
| December 31, 2019 | 53.60M |
| September 30, 2019 | 44.45M |
| June 30, 2019 | 40.07M |
| March 31, 2019 | 40.04M |
| December 31, 2018 | 17.39M |
| September 30, 2018 | 43.97M |
| June 30, 2018 | 32.26M |
| March 31, 2018 | 30.91M |
| December 31, 2017 | 33.32M |
| September 30, 2017 | 30.13M |
| June 30, 2017 | 30.61M |
| March 31, 2017 | 31.86M |
| December 31, 2016 | 59.07M |
| September 30, 2016 | 53.14M |
| June 30, 2016 | 55.24M |
| March 31, 2016 | 63.69M |
| December 31, 2015 | 55.67M |
| September 30, 2015 | 56.31M |
| June 30, 2015 | 52.84M |
| March 31, 2015 | 51.76M |
| December 31, 2014 | 55.89M |
| September 30, 2014 | 7.052M |
| June 30, 2014 | 6.197M |
| March 31, 2014 | 6.770M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Genmab A/S | 6.558B |
| Ascendis Pharma A/S | 971.27M |
| Bavarian Nordic A/S | 230.26M |
| Evaxion AS | 9.849M |
| Novo Nordisk A/S | 57.15B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.023B |
| Shareholders Equity (Quarterly) | 2.753B |
| Debt to Equity Ratio | 0.0228 |
| Current Ratio | 13.98 |
| Net Debt Paydown Yield | -0.04% |